Skip to main content
SAMSUNG PHARMACEUTICAL.CO.,Ltd. logo

SAMSUNG PHARMACEUTICAL.CO.,Ltd. — Investor Relations & Filings

Ticker · 001360 ISIN · KR7001360007 KO Manufacturing
Filings indexed 196 across all filing types
Latest filing 2021-09-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 001360

About SAMSUNG PHARMACEUTICAL.CO.,Ltd.

http://www.sspharm.com/

Samsung Pharmaceutical Co., Ltd. is a company engaged in the research, development, manufacturing, and sale of pharmaceutical products. Its portfolio includes a range of medications, such as antibiotics and liver treatments, with a research focus on therapeutic areas like neoplasms. In addition to its core pharmaceutical operations, the company is also involved in the bio business and the sale of health foods.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (GemVax & KAEL) in Samsung Pharmaceutical. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-09-10 Korean
[기재정정]반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (반기보고서) for Samsung Pharm, covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial data, business operations, and management information. It is not an announcement of a report, but the report itself, and it includes substantive financial data, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-20 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Samsung Pharm, covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial information, business operations, capital structure, and management discussions, which is characteristic of an interim/quarterly report. It is not an announcement of a report, but the report itself. H1 2021
2021-08-13 Korean
풍문또는보도에대한해명(미확정)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Samsung Pharmaceutical regarding a clarification of rumors or reports (풍문 또는 보도에 대한 해명). It addresses a specific regulatory action taken by the Ministry of Food and Drug Safety (MFDS) regarding the suspension of manufacturing and sales of certain products. Since this is a formal regulatory disclosure filed with the exchange (KRX) to clarify market rumors and provide updates on regulatory compliance, it fits best under the 'Regulatory Filings' category as it does not represent a financial report, dividend, or management change.
2021-08-06 Korean
풍문또는보도에대한해명(미확정)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory disclosure regarding a rumor or media report ('풍문 또는 보도에 대한 해명') concerning regulatory actions by the Ministry of Food and Drug Safety against Samsung Pharmaceutical. It is a standard regulatory announcement issued to clarify market rumors, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it falls under the general regulatory filing category.
2021-07-08 Korean
제품에대한수거ㆍ파기등결정
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from Samsung Pharmaceutical regarding a product recall and disposal order issued by the Gyeongin Regional Food and Drug Administration. It details the specific products, financial impact (percentage of revenue), reasons for the recall, and management's response. Since this is a specific regulatory announcement regarding a material event (product recall/legal/regulatory action) that does not fit into financial reporting or corporate governance categories, it is classified as a Regulatory Filing (RNS).
2021-07-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.